KUALA LUMPUR, Malaysia, Sept. 25, 2024 (GLOBE NEWSWIRE) — MRNA Scientific Sdn. Bhd. (“MRNA”), a subsidiary of BioNexus Gene Lab Corp. (Nasdaq: BGLC, the Firm), and Protech Builders Sdn. Bhd. (“Protech”), a number one mechanical and electrical engineering development agency in Malaysia, are happy to announce the signing of a strategic teaming settlement (the Settlement) to collectively develop and function biogas crops throughout Malaysia. This collaboration marks a major step in each firms’ efforts to contribute to Malaysia’s rising renewable power sector, significantly within the era of biogas from plantation wastewater.
Strategic Collaboration for Sustainable Development
Beneath this three-year Settlement, Protech and MRNA will pool their sources and experience to determine, market, and execute biogas initiatives that convert plantation and agricultural wastewater into renewable power. Protech and MRNA have agreed to collectively make an preliminary monetary contribution of as much as RM1,000,000 (Approx. USD 235,000) to fund feasibility research and different mission growth actions.
The partnership will leverage the Firm’s in depth market data and chemical uncooked materials experience, together with Protech’s confirmed capabilities in mechanical and electrical engineering. Protech holds a G7 development license, the very best grade issued by the Building Business Improvement Board (CIDB) Malaysia, which permits them to undertake initiatives of any measurement and worth with out limitations. With over 20 years of expertise and a portfolio of greater than 300 efficiently accomplished initiatives throughout Malaysia, together with biogas services and energy transmission programs, Protech is uniquely positioned to make sure the technical success and well timed completion of those initiatives.
Projected Income and Development Potential
The biogas market in Malaysia presents substantial development alternatives. With the mixed strengths of our Firm and Protech, we anticipate securing a number of biogas initiatives over the following three years, starting from small to large-scale installations.
A Step Towards a Sustainable Future
This teaming settlement represents a strategic alignment of our strengths, stated Sam Tan, CEO of BioNexus Gene Lab Corp. By combining the Firm’s market insights and Protech’s engineering experience, we’re well-positioned to capitalize on the rising demand for biogas options in Malaysia. This partnership not solely helps our mission to contribute to a sustainable future but in addition enhances our income era capabilities.
CW Wong, CEO of Protech Builders, added, We’re excited to associate with BGLC to develop biogas crops that may deliver lasting environmental and financial advantages to Malaysia. Our in depth expertise in establishing advanced engineering programs, together with biogas services and energy transmission, mixed with our G7 license, ensures that we are able to ship top-quality initiatives that meet the very best trade requirements.
About BioNexus Gene Lab Corp.
BioNexus Gene Lab Corp. is an rising Biotech firm and a number one provider of chemical uncooked supplies in Southeast Asia. By way of its subsidiaries, BGLC operates within the Biotech and Chemical Provide Industries all through Southeast Asia.
For extra info, please go to www.bionexusgenelab.com.
About Protech Builders Sdn. Bhd.
Protech Builders Sdn. Bhd. is a famend mechanical and electrical engineering agency in Malaysia, specializing within the set up, commissioning, and upkeep of advanced engineering programs.
For extra info, please go to www.protech.my.
Protected Harbor Assertion
This press launch comprises forward-looking statements as outlined by the Personal Securities Litigation Reform Act of 1995. Ahead-looking statements embody statements regarding plans, aims, targets, methods, future occasions or efficiency, and underlying assumptions and different statements that aren’t statements of historic details. When the Firm makes use of phrases similar to could, will, intend, ought to, consider, count on, anticipate, mission, estimate or comparable expressions that don’t relate solely to historic issues, it’s making forward-looking statements. Ahead-looking statements will not be ensures of future efficiency and contain dangers and uncertainties that will trigger the precise outcomes to vary materially from the Firm’s expectations mentioned within the forward-looking statements. These statements are topic to uncertainties and dangers together with, however not restricted to, the next: the Firm’s targets and techniques; the Firm’s future enterprise growth; product and repair demand and acceptance; adjustments in know-how; financial situations; the expansion of the biotech trade in Malaysia and the opposite markets the Firm serves or plans to serve; status and model; the affect of competitors and pricing; authorities laws; fluctuations generally financial and enterprise situations in Malaysia and the opposite markets the Firm serves or plans to serve and assumptions underlying or associated to any of the foregoing and different dangers contained in reviews filed by the Firm with the Securities and Alternate Fee (the SEC). For these causes, amongst others, traders are cautioned to not place undue reliance upon any forward-looking statements on this press launch. Extra components are mentioned within the Firm’s filings with the SEC, which can be found for assessment at www.sec.gov. The Firm undertakes no obligation to publicly replace these forward-looking statements to mirror occasions or circumstances that come up after the date hereof.
Contact Data:
Investor Relations
BioNexus Gene Lab Corp
E mail: ir@bionexusgenelab.com
A photograph accompanying this announcement is accessible at https://www.globenewswire.com/NewsRoom/AttachmentNg/9eeb7b7c-f13c-444c-9380-17bb100d8b4d
BGLC and Protech Representatives Settlement Handover
Mr. Lai representing BioNexus Gene Lab Corp. (BGLC) and Mr. Wong representing Protech Builders Sdn. Bhd. (Protech) through the handover of agreements
Supply: BioNexus Gene Lab Corp.
